CAGRILINTIDE | SEMAGLUTIDE Blend 10 mg
Original price was: $165.00.$123.75Current price is: $123.75.Cagrilintide + Semaglutide is a dual-agonist research pairing that targets complementary pathways in appetite control, energy regulation, and metabolic balance. Cagrilintide, a long-acting amylin analogue,
RETATRUTIDE (GLP-3) 10mg
Original price was: $120.00.$90.00Current price is: $90.00.Retatrutide is an investigational multi-agonist peptide engineered to activate three metabolic hormone receptors—GLP-1, GIP, and glucagon—positioning it as a next-generation “triple agonist.” In research settings, it has been
RETATRUTIDE (GLP-3) 20mg
Original price was: $195.00.$146.25Current price is: $146.25.Retatrutide is an investigational multi-agonist peptide engineered to activate three metabolic hormone receptors—GLP-1, GIP, and glucagon—positioning it as a next-generation “triple agonist.” In research settings, it has been
RETATRUTIDE (GLP-3) 30mg
Original price was: $250.00.$187.50Current price is: $187.50.Retatrutide is an investigational multi-agonist peptide engineered to activate three metabolic hormone receptors—GLP-1, GIP, and glucagon—positioning it as a next-generation “triple agonist.” In research settings, it has been
SEMAGLUTIDE (GLP-1) 20mg
Original price was: $175.00.$131.25Current price is: $131.25.Semaglutide is a long-acting GLP-1 receptor agonist (GLP-1RA) investigated for its effects on glycemic regulation and body-weight–related outcomes in controlled research settings. It is structurally optimized for extended
SEMAGLUTIDE (GLP-1) 30mg
Original price was: $215.00.$161.25Current price is: $161.25.Semaglutide is a long-acting GLP-1 receptor agonist (GLP-1RA) investigated for its effects on glycemic regulation and body-weight–related outcomes in controlled research settings. It is structurally optimized for extended
SEMAGLUTITDE (GLP-1) 10mg
Original price was: $105.00.$78.75Current price is: $78.75.Semaglutide is a long-acting GLP-1 receptor agonist (GLP-1RA) investigated for its effects on glycemic regulation and body-weight–related outcomes in controlled research settings. It is structurally optimized for extended
TIRZEPATIDE (GLP-2) 10mg
Original price was: $115.00.$86.25Current price is: $86.25.Tirzepatide is a long-acting synthetic polypeptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating both incretin pathways, it has been
TIRZEPATIDE (GLP-2) 20mg
Original price was: $185.00.$138.75Current price is: $138.75.Tirzepatide is a long-acting synthetic polypeptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating both incretin pathways, it has been
TIRZEPATIDE (GLP-2) 30mg
Original price was: $235.00.$176.25Current price is: $176.25.Tirzepatide is a long-acting synthetic polypeptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating both incretin pathways, it has been